Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

James Hardie Industries (JHX) Cash & Equivalents (2017 - 2025)

James Hardie Industries (JHX) has disclosed Cash & Equivalents for 16 consecutive years, with $562.7 million as the latest value for Q1 2025.

  • On a quarterly basis, Cash & Equivalents rose 54.16% to $562.7 million in Q1 2025 year-over-year; TTM through Mar 2025 was $562.7 million, a 54.16% increase, with the full-year FY2025 number at $562.7 million, up 54.16% from a year prior.
  • Cash & Equivalents was $562.7 million for Q1 2025 at James Hardie Industries, up from $365.0 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $562.7 million in Q1 2025 to a low of $113.0 million in Q1 2023.
  • A 5-year average of $274.8 million and a median of $208.5 million in 2021 define the central range for Cash & Equivalents.
  • Peak YoY movement for Cash & Equivalents: crashed 40.05% in 2022, then surged 223.01% in 2024.
  • James Hardie Industries' Cash & Equivalents stood at $208.5 million in 2021, then tumbled by 40.05% to $125.0 million in 2022, then dropped by 9.6% to $113.0 million in 2023, then soared by 223.01% to $365.0 million in 2024, then soared by 54.16% to $562.7 million in 2025.
  • Per Business Quant, the three most recent readings for JHX's Cash & Equivalents are $562.7 million (Q1 2025), $365.0 million (Q1 2024), and $113.0 million (Q1 2023).